Effect of taxanes on the miR-106 and miR-200c expression in prostate cancer cells in vivo and in vitro

Effect of taxanes on the miR-106 and miR-200c expression in prostate cancer cells in vivo and in vitro

Introduction. A combination of antiandrogen and cytostatic drugs was justified in the neoadjuvant therapy of patients with high-risk prostate cancer (HiRPCa) in some clinical trials. The effectiveness of such therapy in each individual case depends on the sensitivity of cancer cells to the applied d...

Full description

Saved in:
Bibliographic Details
Main Authors: D. S. Plevako, M. S. Knyazeva, E. I. Sidina, M. V. Berkut, S. A. Reva, S. S. Tolmachev, A. S. Artemyeva, A. K. Nosov, A. V. Malek
Format: Article
Language:Russian
Published: Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education 2023-01-01
Series:Вестник урологии
Subjects:
prostate cancer
microrna
taxanes
docetaxel
paclitaxel
Online Access:https://www.urovest.ru/jour/article/view/629
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items